510(k) · Cleared
Recalled · Class II · 2014Heparin Lock Flush Solution Usp, Models 504401, 504411, 504505, 505701, 504901, 1710
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
App Pharmaceuticals, LLC · NZW Heparin, Vascular Access Flush
Cleared on Jun 18, 2010 as substantially equivalent to K001795 (Avitro, LLC, 2000) after a 267-day review. Its family tree reaches back 1 generation to 2000. It has been recalled once.
- Decided
- Jun 18, 2010
- Review
- 267 days
- Class
- Class II
- Product code
- NZW
- Recalls
- 1
- Predicates
- 1
Its longest line of descent runs back 1 generation to K001795 (2000). No later device cites it as a predicate yet.
- Root · 1 generation backK001795 The Avitro LLC, 10 and 100 Uso Units/ML Heparin Sodium VafdAvitro, LLC · 2000
- This deviceK092938 Heparin Lock Flush Solution Usp, Models 504401, 504411, 504505…App Pharmaceuticals, LLC · 2010
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −1 | K001795 | The Avitro LLC, 10 and 100 Uso Units/ML Heparin Sodium Vafd | Avitro, LLC | 2000 | — |
| 0 (this device) | K092938 | Heparin Lock Flush Solution Usp, Models 504401, 504411, 504505, 505701… | App Pharmaceuticals, LLC | 2010 | — |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in NZW? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
- Candidate predicates for a device like this, rankedin the report
- Recall history across each candidate’s familyin the report
What was it cleared against? (1)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K001795 | The Avitro LLC, 10 and 100 Uso Units/ML Heparin Sodium VafdSummary page 2…claims the proposed devices to be substantially equivalent to the devices previously cleared by FDA in K001 795. APP claims this equivalence because the proposed devices have an equivalent… | 2000 |
What descends from it?
No later submission names this one as a predicate yet.
Has anything in its family been recalled? (0 Class I)
Recalls of this device
| Date | Class | Recall | Root cause | Reason |
|---|---|---|---|---|
| Dec 19, 2014 | Class II | Z-1032-2015 | Component design/selection | The lot failed pH specification. |
No ancestor or descendant has a Class I recall.
What does this lineage say?
- Its one ancestor has no recall.
How does its category compare?
All NZW devicesNZW Heparin, Vascular Access Flush: FDA decisions, review times, recalls and adverse event reports over 20 years. 2010, this device’s year, is highlighted.
FDA decisions per year · NZW
1in 2017
2026 to Oct 25, outlined.
Median 510(k) review, days · NZW
Too few NZW 510(k)s in any year since 2007 to give a median.
Recalls per year · NZW
1in 2014
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · NZW
11in 2025
MAUDE reports naming product code NZW, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 1 | — | 0 | 21 |
| 2008 | 0 | — | 22 | 291 |
| 2009 | 1 | — | 0 | 122 |
| 2010 | 2 | — | 3 | 194 |
| 2011 | 0 | — | 0 | 33 |
| 2012 | 0 | — | 1 | 9 |
| 2013 | 0 | — | 0 | 15 |
| 2014 | 1 | — | 1 | 8 |
| 2015 | 0 | — | 0 | 5 |
| 2016 | 0 | — | 0 | 0 |
| 2017 | 1 | — | 0 | 3 |
| 2018 | 0 | — | 0 | 19 |
| 2019 | 0 | — | 0 | 19 |
| 2020 | 0 | — | 0 | 3 |
| 2021 | 0 | — | 0 | 10 |
| 2022 | 0 | — | 0 | 14 |
| 2023 | 0 | — | 0 | 9 |
| 2024 | 0 | — | 0 | 10 |
| 2025 | 0 | — | 0 | 11 |
| 2026 | 0 | — | 0 | — |
What is it indicated for?
Heparin Lock Flush Solution, USP product code 505701 (10 Units/mL) and product code 504901 (100 USP Units/mL) is intended to maintain patency of an indwelling venipuncture device designed for intermittent injection or infusion therapy or blood sampling.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K092938 · printed Nov 4, 2026
Cite this page
510(k) Report. “K092938: Heparin Lock Flush Solution Usp, Models 504401, 504411, 504505, 505701, 504901, 1710.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K092938
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026